Drug Manufacturers - Specialty & Generic | Healthcare
NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
Market Cap
₹ 1,58,45,86,26,048
Current Price
₹ 884.7
52 Week Range
726.8 - 1639.0
Previous Close
₹ 881.65
Open
₹ 889.9
Sector
Healthcare
Address
Natco House, Road No. 2 Banjara Hills, Hyderabad, 500034, India
Phone
+91-40235-47532
Fax
+91-40235-48243
Website
https://www.natcopharma.co.in
Day Low
₹ 880.85
Day High
₹ 893.65
Dividend Yield
0.84
PE Ratio
8.225177
Earnings Per Share
₹ 107.56
Beta
0.312
EBITDA
₹ 21,95,99,99,488
Book Value
₹ 424.69
EPS
₹ 69.8
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Venkaiah Chowdary Nannapaneni M. Pharm, MS. | MD & Chairman | 79 | 1945 |
Mr. Rajeev Nannapaneni | CEO & Vice Chairman | 47 | 1977 |
Mr. S. V. V. N. Appa Rao | Chief Financial Officer | - | - |
Dr. Donthineni Linga Rao M.D. | President of Technical Affairs & Whole Time Director | 72 | 1952 |
Mr. Chekuri Venkat Ramesh C.S. | Company Secretary & Compliance Officer | - | - |
Mr. Potluri Sivaramakrishna Prasad | Executive VP of Corporate Engineering Services & Whole Time Director | 66 | 1958 |
Nadella Malleswara Rao | VP & Head of Operations | - | - |
N. Sadasiva Rao | Executive Vice President of Corporate Affairs, Legal, Secretarial & Estate Management | - | - |
James Rajakumar | Vice President of Marketing & Sales - Domestic | - | - |
Mr. A. Lakshminarayana | Senior Vice President of HR & Organisational Development | 61 | 1963 |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.